Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience.

J Family Community Med · 2023 · PMC10688587 · PMID 38044971

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significanceP = 0.14not close (p > 0.1)

There was also an improvement in kidney functions; eGFR improved from a mean (SD) of 69.83 (26.66) to 71.68 (28.91) mL/min after treatment but did not reach statistical significance ( P = 0.14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.